| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0700432.8AGB0700432D0 (en) | 2007-01-10 | 2007-01-10 | Therapeutic compounds |
| Publication Number | Publication Date |
|---|---|
| CR10910Atrue CR10910A (en) | 2010-01-19 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10910ACR10910A (en) | 2007-01-10 | 2009-07-02 | INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP) |
| Country | Link |
|---|---|
| CN (1) | CN101578279B (en) |
| AT (1) | ATE502933T1 (en) |
| CR (1) | CR10910A (en) |
| DE (1) | DE602008005711D1 (en) |
| DK (2) | DK2336120T3 (en) |
| ES (3) | ES2362214T3 (en) |
| GB (1) | GB0700432D0 (en) |
| HN (1) | HN2009001260A (en) |
| HU (1) | HUE044513T2 (en) |
| LT (1) | LT2805945T (en) |
| LU (1) | LUC00072I2 (en) |
| ME (1) | ME03481B (en) |
| MY (1) | MY147789A (en) |
| NI (1) | NI200900135A (en) |
| NZ (1) | NZ578256A (en) |
| PE (1) | PE20081558A1 (en) |
| PT (3) | PT2805945T (en) |
| SI (2) | SI2336120T1 (en) |
| TW (1) | TWI528961B (en) |
| UA (1) | UA97658C2 (en) |
| ZA (1) | ZA200903898B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106496187A (en)* | 2016-09-14 | 2017-03-15 | 陕西科技大学 | A kind of synthetic method for preparing PARP inhibitor Niraparib |
| CN106432188A (en)* | 2016-09-17 | 2017-02-22 | 青岛辰达生物科技有限公司 | Preparation method of anti-cancer drug 2-[4-((3S)-3-Piperidinyl) phenyl]-2H-Indazole-7-Formamide |
| CN106432187A (en)* | 2016-09-17 | 2017-02-22 | 青岛云天生物技术有限公司 | Chiral resolution method of 2-[4-(-3-piperidyl)phenyl]-2H-indazole-7-formamide |
| CN106632244A (en)* | 2016-09-30 | 2017-05-10 | 陕西科技大学 | A novel synthetic method for preparing an anticancer medicine Niraparib |
| CN106467513A (en)* | 2016-09-30 | 2017-03-01 | 陕西科技大学 | A kind of synthetic method preparing Niraparib |
| CN108201537A (en)* | 2016-12-16 | 2018-06-26 | 苏州苏融生物医药有限公司 | A kind of Ni Lapani sustained and controlled release medicaments composition and application thereof |
| WO2018183349A1 (en)* | 2017-03-27 | 2018-10-04 | Tesaro, Inc. | Niraparib formulations |
| CN109081828B (en)* | 2017-06-14 | 2021-03-26 | 上海时莱生物技术有限公司 | Poly (ADP-ribose) polymerase inhibitor, preparation method and application |
| CN111278433A (en) | 2017-09-26 | 2020-06-12 | 特沙诺有限公司 | Nilaparib formulations |
| CN108084157A (en)* | 2018-02-12 | 2018-05-29 | 安庆奇创药业有限公司 | A kind of synthetic method of Ni Lapani |
| CN108203404A (en)* | 2018-03-02 | 2018-06-26 | 上海博邦医药科技有限公司 | (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani |
| US20240016775A1 (en) | 2020-02-24 | 2024-01-18 | Fukang (Shanghai) Health Technology Co., Ltd | Anti-coronavirus application of poly adp ribose polymerase inhibitor |
| CN115611860B (en)* | 2021-07-13 | 2024-06-11 | 上海博璞诺科技发展有限公司 | Method for synthesizing nilaparib |
| Publication number | Publication date |
|---|---|
| CN101578279B (en) | 2013-07-17 |
| MY147789A (en) | 2013-01-31 |
| DK2109608T3 (en) | 2011-07-11 |
| SI2109608T1 (en) | 2011-07-29 |
| LT2805945T (en) | 2019-06-25 |
| TW200836731A (en) | 2008-09-16 |
| ATE502933T1 (en) | 2011-04-15 |
| ES2509115T3 (en) | 2014-10-17 |
| HN2009001260A (en) | 2012-03-26 |
| DK2336120T3 (en) | 2014-10-06 |
| DE602008005711D1 (en) | 2011-05-05 |
| ME03481B (en) | 2020-01-20 |
| UA97658C2 (en) | 2012-03-12 |
| HUE044513T2 (en) | 2019-10-28 |
| ES2362214T3 (en) | 2011-06-29 |
| PE20081558A1 (en) | 2008-10-30 |
| PT2336120E (en) | 2014-10-01 |
| GB0700432D0 (en) | 2007-02-21 |
| NZ578256A (en) | 2011-12-22 |
| CN101578279A (en) | 2009-11-11 |
| ZA200903898B (en) | 2010-04-28 |
| PT2109608E (en) | 2011-05-30 |
| NI200900135A (en) | 2010-08-30 |
| TWI528961B (en) | 2016-04-11 |
| PT2805945T (en) | 2019-06-06 |
| SI2336120T1 (en) | 2014-10-30 |
| LUC00072I2 (en) | 2018-07-04 |
| ES2728199T3 (en) | 2019-10-22 |
| Publication | Publication Date | Title |
|---|---|---|
| HN2009001260A (en) | INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADPRIBOSE) POLYMERASE (PARP) | |
| ECSP099484A (en) | INDAZOLS REPLACED WITH AMIDA AS INHIBITORS OF | |
| MX2010005070A (en) | Pyridazinone derivatives as parp inhibitors. | |
| WO2007138351A3 (en) | Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) | |
| CR20110077A (en) | DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL | |
| MX2012002179A (en) | Heterocyclic oxime compounds. | |
| BR112015002293A2 (en) | dihydropyridone pi as xia factor inhibitors | |
| WO2008103277A3 (en) | Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors | |
| MX2013001204A (en) | Compounds for the treatment/prevention of ocular inflammatory diseases. | |
| MX2012001838A (en) | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation. | |
| MX2011011854A (en) | Dihydropyrimidinones for use as bace2 inhibitors. | |
| DOP2011000081A (en) | BENZAMIDA REPLACED AS LIGANDS OF THE CANABINOID RECEIVER | |
| WO2008017883A3 (en) | 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) | |
| CY1118818T1 (en) | 1- [1- (BENZOYL) -PYRROLIDINO-2-CARBONYL] -PYRROLIDINO-2-CARBONYL | |
| MX2011013869A (en) | Anthelmintic agents and their use. | |
| PH12015500418A1 (en) | Pyridine derivative and medicine |